4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Curaleaf Holdings, Inc. (CURA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Stamford, United States with about 5,554 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, CURA reported $1.3B in revenue and ($273M) in net income.
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $1.3B | $1.3B | $1.3B | $1.3B |
| Gross Profit | $631M | $641M | $614M | $626M |
| Operating Income (EBIT) | $25M | $25M | $43M | $65M |
| Net Income | ($273M) | ($238M) | ($281M) | ($370M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $340M | $324M | $323M | $320M | $311M | — |
| Gross Profit | $170M | $157M | $164M | $160M | $153M | — |
| Operating Income (EBIT) | $4M | $1M | $10M | $4M | $6M | — |
| Net Income | $12M | $70M | ($102M) | ($57M) | ($53M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $2.8B | $2.9B | $3.1B | $3.4B | — |
| Total Liabilities | $2.0B | $2.0B | $1.9B | $2.0B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CURA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms